Forfenimex is a newly discovered low molecular weight immunomodifier. References: Murphy KT, Wardak A, Beckett MA, Lopez CA, Mehta N, Kimchi E, Salloum RM, Jaskowiak NT, Posner MC, Ohno T, Kufe DW, Weichselbaum RR, Mauceri HJ. Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma. Cancer Chemother Pharmacol. 2005 Sep;56(3):317-21. Epub 2005 May 11. PubMed PMID: 15887016.

纯度：≥98%

CAS：71522-58-2